secwatch.observer — SEC 8-K summary
======================================

Issuer:     Beam Therapeutics Inc. (BEAM)
CIK:        0001745999
Form:       8-K
Filed at:   2024-07-15T23:59:59+00:00
Accession:  0001193125-24-178824
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Beam Therapeutics CFO Terry-Ann Burrell resigns; CEO John Evans named interim principal financial officer
--------------------------------------------------------------------------------

- CFO Terry-Ann Burrell resigns effective Aug 9, 2024 to join JPMorgan as vice chairman of investment banking.
- CEO John Evans appointed Principal Financial and Accounting Officer upon her departure, continuing as CEO.
- Company initiates search for a permanent CFO successor.
- Burrell had served as CFO for 5 years, overseeing IPO and capital raising efforts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1745999/000119312524178824/0001193125-24-178824-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1745999/000119312524178824/d723042d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-178824

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer